FBN1 and acromelic dysplasia: This suggests that, as in the case of the SSS mutants, the acromelic dysplasia mutants may be acting at the level of cell–matrix interactions rather than disrupting microfibril assembly and that heparan sulphate interactions involving this region of fibrillin-1 are not critical for assembly.